Repotrectinib
Repotrectinib is a tyrosine kinase inhibitor (TKI) that is being developed for the treatment of various types of cancer. It is particularly targeted towards cancers that have specific genetic alterations, such as ROS1, NTRK, and ALK gene fusions. Repotrectinib is designed to overcome resistance to other TKIs and has shown promise in early clinical trials.
Mechanism of Action[edit | edit source]
Repotrectinib works by inhibiting the activity of certain tyrosine kinases, which are enzymes that play a crucial role in the signaling pathways that regulate cell division and survival. By blocking these kinases, repotrectinib can prevent the growth and spread of cancer cells. It is particularly effective against cancers with ROS1, NTRK, and ALK gene fusions, which are known to drive the growth of certain tumors.
Clinical Development[edit | edit source]
Repotrectinib is currently undergoing clinical trials to evaluate its safety and efficacy. Early results have shown that it can be effective in patients who have developed resistance to other TKIs. The drug is being tested in various phases of clinical trials, including Phase I, Phase II, and Phase III studies.
Indications[edit | edit source]
Repotrectinib is being investigated for the treatment of several types of cancer, including:
- Non-small cell lung cancer (NSCLC) with ROS1 or NTRK gene fusions
- Solid tumors with NTRK gene fusions
- ALK-positive cancers
Side Effects[edit | edit source]
As with other TKIs, repotrectinib can cause a range of side effects. Common side effects include:
Future Directions[edit | edit source]
Research is ongoing to determine the full potential of repotrectinib in treating various cancers. Scientists are also exploring its use in combination with other therapies to enhance its effectiveness and overcome resistance mechanisms.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
